Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2014 1
2015 1
2016 1
2017 1
2018 2
2020 3
2021 2
2022 1
2023 3
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Bakouni H, Sharafi H, Bahremand A, Drouin S, Ziegler D, Bach P, Le Foll B, Schütz CG, Tardelli V, Ezard N, Siefried K, Jutras-Aswad D. Bakouni H, et al. Drug Alcohol Depend. 2023 Dec 1;253:111018. doi: 10.1016/j.drugalcdep.2023.111018. Epub 2023 Nov 4. Drug Alcohol Depend. 2023. PMID: 37979478
Random-effect meta-analysis was conducted presenting standardized mean difference (SMD), risk ratio (RR), and risk difference (RD). RESULTS: Eight RCTs (total N=1239 participants) were included. Bupropion compared to placebo was associated with reduced ATS use (RR: 0.90; 9 …
Random-effect meta-analysis was conducted presenting standardized mean difference (SMD), risk ratio (RR), and risk difference (RD). RESULTS: …
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, Bach P, Ezard N, Le Foll B, Schütz CG, Siefried KJ, Tardelli VS, Ziegler D, Jutras-Aswad D. Sharafi H, et al. Addiction. 2024 Feb;119(2):211-224. doi: 10.1111/add.16347. Epub 2023 Oct 25. Addiction. 2024. PMID: 37880829
Mean difference and standardized mean difference (SMD) were calculated for random-effect meta-analysis of continuous variables. RESULTS: Ten RCTs (n = 561 participants) were included in the meta-analysis. Trials studied methylphenidate (n = 7), with daily doses of 5 …
Mean difference and standardized mean difference (SMD) were calculated for random-effect meta-analysis of continuous variables. RESULTS: Ten …
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.
Eshraghi A, Talasaz AH, Salamzadeh J, Salarifar M, Pourhosseini H, Nozari Y, Bahremand M, Jalali A, Boroumand MA. Eshraghi A, et al. Am J Ther. 2016 Jan-Feb;23(1):e44-51. doi: 10.1097/MJT.0000000000000309. Am J Ther. 2016. PMID: 26291594 Clinical Trial.
The aim of this study was to determine the effect of the intracoronary administration of high-dose N-acetylcysteine (NAC) for the evaluation of its antiplatelet effects in human subjects. ...Finally, 100 patients were randomized to receive high-dose intracoronary NAC (100 …
The aim of this study was to determine the effect of the intracoronary administration of high-dose N-acetylcysteine (NAC) for the eva …
The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial.
McAnulty C, Bastien G, Abboud A, Bahremand A, Ledjiar O, Socias ME, Le Foll B, Juteau LC, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. McAnulty C, et al. J Subst Use Addict Treat. 2025 Sep;176:209743. doi: 10.1016/j.josat.2025.209743. Epub 2025 Jun 24. J Subst Use Addict Treat. 2025. PMID: 40571059 Free article. Clinical Trial.
METHODS: Our data came from the OPTIMA trial - a pan-Canadian, pragmatic, open-label, randomized controlled trial that compared a flexible, early take-home buprenorphine/naloxone model of care (n = 137) to standard treatment with methadone (n = 132) for non-heroin o …
METHODS: Our data came from the OPTIMA trial - a pan-Canadian, pragmatic, open-label, randomized controlled trial that compared a flexible, …
Involvement of N-Methyl-D-Aspartate Receptors in the Anticonvulsive Effects of Licofelone on Pentylenetetrazole-Induced Clonic Seizure in Mice.
Gholizadeh R, Abdolmaleki Z, Bahremand T, Ghasemi M, Gharghabi M, Dehpour AR. Gholizadeh R, et al. J Epilepsy Res. 2021 Jun 30;11(1):14-21. doi: 10.14581/jer.21003. eCollection 2021 Jun. J Epilepsy Res. 2021. PMID: 34395219 Free PMC article.
We have recently demonstrated a role for nitric oxide (NO) signaling in the anti-epileptic activity of licofelone in two seizure models in rodents. Given the important role of N-methyl-D-aspartate receptors (NMDARs) activation in the NO production and its function in the n …
We have recently demonstrated a role for nitric oxide (NO) signaling in the anti-epileptic activity of licofelone in two seizure models in r …
Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.
Nozari Y, Eshraghi A, Talasaz AH, Bahremand M, Salamzadeh J, Salarifar M, Pourhosseini H, Jalali A, Mortazavi SH. Nozari Y, et al. Am J Cardiovasc Drugs. 2018 Jun;18(3):213-221. doi: 10.1007/s40256-017-0258-8. Am J Cardiovasc Drugs. 2018. PMID: 29322434 Clinical Trial.
Recent studies have shown that the antioxidant properties of N-acetylcysteine (NAC) may have cardioprotective effects in high doses, but-to the best of our knowledge-few studies have assessed this. ...
Recent studies have shown that the antioxidant properties of N-acetylcysteine (NAC) may have cardioprotective effects in high doses, …
A comparison of CrossFit and concurrent training on myonectin, insulin resistance and physical performance in healthy young women.
Bahremand M, Hakak Dokht E, Moazzami M. Bahremand M, et al. Arch Physiol Biochem. 2023 Jun;129(3):603-609. doi: 10.1080/13813455.2020.1853173. Epub 2020 Dec 1. Arch Physiol Biochem. 2023. PMID: 33259247
MATERIALS AND METHODS: Thirty healthy women were randomly assigned to CrossFit (n = 16) and CT (n = 14) groups, exercising three sessions per week for eight weeks. ...
MATERIALS AND METHODS: Thirty healthy women were randomly assigned to CrossFit (n = 16) and CT (n = 14) groups, exercising thr …
Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A Randomized Controlled Trial.
Shojaei L, Esfandiary S, Rouzbahani M, Heydarpour F, Bahremand M, Heidary Moghadam R, Mahmoudi G, Korani F, Raissi F, Shahbazi F. Shojaei L, et al. Iran J Pharm Res. 2022 Jun 14;21(1):e126920. doi: 10.5812/ijpr-126920. eCollection 2022 Dec. Iran J Pharm Res. 2022. PMID: 36060925 Free PMC article.
In this randomized clinical trial, a total of 110 eligible CKD stage 3 patients requiring contrast agent administration for coronary angiography/angioplasty were enrolled and randomly assigned to either crocin (n = 57) or control (n = 53) group. The patients in both …
In this randomized clinical trial, a total of 110 eligible CKD stage 3 patients requiring contrast agent administration for coronary angiogr …
Interaction of morphine tolerance with pentylenetetrazole-induced seizure threshold in mice: The role of NMDA-receptor/NO pathway.
Zamanian G, Shayan M, Rahimi N, Bahremand T, Shafaroodi H, Ejtemaei-Mehr S, Aghaei I, Dehpour AR. Zamanian G, et al. Epilepsy Behav. 2020 Nov;112:107343. doi: 10.1016/j.yebeh.2020.107343. Epub 2020 Aug 2. Epilepsy Behav. 2020. PMID: 32755816
N-methyl-d-aspartate receptor (NMDA-R)/nitric oxide (NO) pathway is involved in the intensification of the analgesic effect of opioids and the reduction of the intensity of opioids tolerance and dependence. ...
N-methyl-d-aspartate receptor (NMDA-R)/nitric oxide (NO) pathway is involved in the intensification of the analgesic effect of opioid …
Modulation of the anticonvulsant effect of swim stress by agmatine.
Bahremand T, Payandemehr P, Riazi K, Noorian AR, Payandemehr B, Sharifzadeh M, Dehpour AR. Bahremand T, et al. Epilepsy Behav. 2018 Jan;78:142-148. doi: 10.1016/j.yebeh.2017.11.005. Epub 2017 Dec 22. Epilepsy Behav. 2018. PMID: 29195160
This effect was significantly reversed by NO synthase inhibitor N(G)-nitro-l-arginine (L-NAME (Nomega-Nitro-L-arginine methyl ester), 5mg/kg), suggesting an NO-dependent mechanism, and was unaffected by NTX (10mg/kg), proving little role for endogenous opioids in the inter …
This effect was significantly reversed by NO synthase inhibitor N(G)-nitro-l-arginine (L-NAME (Nomega-Nitro-L-arginine methyl ester), …
19 results